Cargando…
PADI1 and Its Co-Expressed Gene Signature Unveil Colorectal Cancer Prognosis and Immunotherapy Efficacy
Peptidyl arginine deiminase 1 (PADI1) catalyzes protein citrullination and has a role in regulating immune responses. The tumor immune microenvironment has been reported to be important in colorectal cancer (CRC), which was correlated with the ability of CRC patients to benefit from immunotherapy. H...
Autores principales: | Zhang, Yi-ran, Zhang, Lei, Li, Feng, He, Jia-shuai, Xuan, Jin-feng, Chen, Cong-cong, Gong, Chao, Pan, Yun-long |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719422/ https://www.ncbi.nlm.nih.gov/pubmed/36471887 http://dx.doi.org/10.1155/2022/8394816 |
Ejemplares similares
-
Multiomics Analysis Reveals Cuproptosis-Related Signature for Evaluating Prognosis and Immunotherapy Efficacy in Colorectal Cancer
por: He, Rong, et al.
Publicado: (2023) -
PADI4 and tumourigenesis
por: Chang, Xiaotian, et al.
Publicado: (2010) -
Unveiling efferocytosis-related signatures through the integration of single-cell analysis and machine learning: a predictive framework for prognosis and immunotherapy response in hepatocellular carcinoma
por: Liu, Tao, et al.
Publicado: (2023) -
Two Similar Signatures for Predicting the Prognosis and Immunotherapy Efficacy of Stomach Adenocarcinoma Patients
por: Yue, Taohua, et al.
Publicado: (2021) -
PADI2 Is Significantly Associated with Rheumatoid Arthritis
por: Chang, Xiaotian, et al.
Publicado: (2013)